drugset / Trial / NCT03653403

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

NCT03653403

Phase 1 Completed 61 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Control Gel.

Timeline

Start
2018-08-08
Primary completion
2019-06-19
Completion
2019-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified Topical
Subject Clindamycin Unknown Topical

Indications